MyoKardia Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
5,916.00
14,199.00
39,199.00
22,500.00
33,558
Cost of Goods Sold (COGS) incl. D&A
478.00
-
-
-
-
-
Gross Income
478.00
-
-
-
-
-
SG&A Expense
13,154.00
22,422.00
36,447.00
51,393.00
68,815.00
105,642
EBIT
13,632.00
17,218.00
23,213.00
13,305.00
47,609.00
73,651
Unusual Expense
932.00
387.00
314.00
-
-
-
Non Operating Income/Expense
-
-
47.00
153.00
1,657.00
5,953
Pretax Income
12,700.00
16,829.00
22,946.00
13,152.00
45,952.00
67,698
Consolidated Net Income
12,700.00
16,829.00
22,946.00
13,152.00
45,952.00
67,698
Net Income
12,700.00
16,829.00
22,946.00
13,152.00
45,952.00
67,698
Net Income After Extraordinaries
12,700.00
16,829.00
22,946.00
13,152.00
45,952.00
67,698
Net Income Available to Common
13,966.00
19,851.00
28,195.00
13,152.00
45,952.00
67,698
EPS (Basic)
3.26
3.07
4.48
0.48
1.40
1.76
Basic Shares Outstanding
26,196.10
26,196.10
6,292.80
27,475.80
32,832.50
38,386.90
EPS (Diluted)
0.53
0.76
4.48
0.48
1.40
1.76
Diluted Shares Outstanding
26,196.10
26,196.10
6,292.80
27,475.80
32,832.50
38,386.90
EBITDA
13,154.00
16,506.00
22,248.00
12,194.00
46,315.00
72,084
Non-Operating Interest Income
-
2.00
-
-
-
-
Preferred Dividends
1,266.00
3,022.00
5,249.00
-
-
-
About MyoKardia
View Profile
